HEADER TRANSFERASE 05-OCT-10 3P3V TITLE CRYSTAL STRUCTURE OF A PTS DEPENDENT N-ACETYL-GALACTOSAMINE-IIB TITLE 2 COMPONENT (AGAV, SPY_0631) FROM STREPTOCOCCUS PYOGENES AT 1.65 A TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PTS SYSTEM, N-ACETYLGALACTOSAMINE-SPECIFIC IIB COMPONENT; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PUTATIVE PTS DEPENDENT N-ACETYL-GALACTOSAMINE-IIB COMPONENT; COMPND 5 EC: 2.7.1.69; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PYOGENES SEROTYPE M1; SOURCE 3 ORGANISM_TAXID: 301447; SOURCE 4 GENE: AGAV, M5005_SPY0521, SPY_0631; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS PTS IIB COMPONENT, PHOSPHOTRANSFERASE, SUGAR TRANSPORT, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-BIOLOGY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 4 01-FEB-23 3P3V 1 REMARK SEQADV LINK REVDAT 3 25-OCT-17 3P3V 1 REMARK REVDAT 2 20-JUL-11 3P3V 1 KEYWDS REVDAT 1 27-OCT-10 3P3V 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF A PTS DEPENDENT JRNL TITL 2 N-ACETYL-GALACTOSAMINE-IIB COMPONENT (AGAV, SPY_0631) FROM JRNL TITL 3 STREPTOCOCCUS PYOGENES AT 1.65 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 36401 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.160 REMARK 3 R VALUE (WORKING SET) : 0.158 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1816 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2546 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.96 REMARK 3 BIN R VALUE (WORKING SET) : 0.2280 REMARK 3 BIN FREE R VALUE SET COUNT : 119 REMARK 3 BIN FREE R VALUE : 0.2580 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2488 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 293 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.72 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.66000 REMARK 3 B22 (A**2) : -0.93000 REMARK 3 B33 (A**2) : 0.88000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.16000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.094 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.094 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.062 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.650 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.957 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2636 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1716 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3592 ; 1.550 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4269 ; 0.902 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 348 ; 4.944 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;38.235 ;25.701 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 466 ;11.700 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ; 9.895 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 445 ; 0.092 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2908 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 467 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1668 ; 1.770 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 669 ; 0.534 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2748 ; 2.931 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 968 ; 4.522 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 834 ; 6.759 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 162 REMARK 3 ORIGIN FOR THE GROUP (A): 34.6098 4.5444 24.7974 REMARK 3 T TENSOR REMARK 3 T11: 0.0401 T22: 0.0160 REMARK 3 T33: 0.0051 T12: 0.0088 REMARK 3 T13: -0.0043 T23: -0.0055 REMARK 3 L TENSOR REMARK 3 L11: 0.6730 L22: 1.2004 REMARK 3 L33: 1.7571 L12: -0.1715 REMARK 3 L13: -0.2499 L23: 0.1458 REMARK 3 S TENSOR REMARK 3 S11: 0.0085 S12: -0.0104 S13: 0.0480 REMARK 3 S21: 0.0577 S22: -0.0042 S23: -0.0136 REMARK 3 S31: 0.0535 S32: -0.0094 S33: -0.0043 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 0 B 162 REMARK 3 ORIGIN FOR THE GROUP (A): 23.7636 21.5993 7.2609 REMARK 3 T TENSOR REMARK 3 T11: 0.0076 T22: 0.0609 REMARK 3 T33: 0.0425 T12: 0.0001 REMARK 3 T13: -0.0037 T23: -0.0053 REMARK 3 L TENSOR REMARK 3 L11: 1.1823 L22: 1.6644 REMARK 3 L33: 0.7012 L12: -0.4410 REMARK 3 L13: 0.2947 L23: -0.3666 REMARK 3 S TENSOR REMARK 3 S11: -0.0324 S12: -0.0117 S13: 0.0259 REMARK 3 S21: 0.0561 S22: 0.0502 S23: 0.1833 REMARK 3 S31: -0.0137 S32: -0.0511 S33: -0.0178 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL REMARK 3 S-MET INCORPORATION. 3. ATOM RECORDS CONTAIN SUM OF TLS AND REMARK 3 RESIDUAL B FACTORS. ANISOU RECORDS CONTAIN SUM OF TLS AND REMARK 3 RESIDUAL U FACTORS. 4. WATERS WERE EXCLUDED FROM AUTOMATIC TLS REMARK 3 ASSIGNMENT. 5. POLYETHYLENE GLYCOL (PEG AND PGE) FROM THE REMARK 3 CRYSTALLIZATION/CRYOPROTECTANT SOLUTION HAS BEEN MODELED IN THE REMARK 3 SOLVENT STRUCTURE. REMARK 4 REMARK 4 3P3V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1000061922. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96109,0.97934,0.97920 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.15 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36409 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 28.638 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05900 REMARK 200 FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.49100 REMARK 200 R SYM FOR SHELL (I) : 0.49100 REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30.00% POLYETHYLENE GLYCOL 6000, 0.1M REMARK 280 HEPES PH 7.0, ADDITIVE: 0.005 M MANNOSE, NANODROP, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.34800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CRYSTAL PACKING ANALYSIS AND ANALYTICAL SIZE-EXCLUSION REMARK 300 CHROMATOGRAPHY SUPPORT THE ASSIGNMENT OF A MONOMER AS THE REMARK 300 SIGNIFICANT OLIGOMERIC STATE IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 25 CG CD CE NZ REMARK 470 LYS A 145 CD CE NZ REMARK 470 ASN A 151 CG OD1 ND2 REMARK 470 SER A 152 OG REMARK 470 THR B 2 OG1 CG2 REMARK 470 LYS B 43 CG CD CE NZ REMARK 470 LYS B 50 CG CD CE NZ REMARK 470 ILE B 70 CD1 REMARK 470 ASP B 113 CG OD1 OD2 REMARK 470 ASN B 151 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 263 O HOH B 335 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 15 -125.14 54.05 REMARK 500 LEU B 15 -130.14 45.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE B 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 203 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 399539 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3P3V A 1 162 UNP Q9A0T4 Q9A0T4_STRP1 1 162 DBREF 3P3V B 1 162 UNP Q9A0T4 Q9A0T4_STRP1 1 162 SEQADV 3P3V GLY A 0 UNP Q9A0T4 EXPRESSION TAG SEQADV 3P3V GLY B 0 UNP Q9A0T4 EXPRESSION TAG SEQRES 1 A 163 GLY MSE THR GLN PRO ASN ILE ILE MSE THR ARG VAL ASP SEQRES 2 A 163 GLU ARG LEU ILE HIS GLY GLN GLY GLN LEU TRP VAL LYS SEQRES 3 A 163 PHE LEU ASN CYS ASN THR VAL ILE VAL ALA ASN ASP ALA SEQRES 4 A 163 VAL SER GLU ASP LYS ILE GLN GLN SER LEU MSE LYS THR SEQRES 5 A 163 VAL ILE PRO SER SER ILE ALA ILE ARG PHE PHE SER ILE SEQRES 6 A 163 GLN LYS VAL ILE ASP ILE ILE HIS LYS ALA SER PRO ALA SEQRES 7 A 163 GLN SER ILE PHE ILE VAL VAL LYS ASP LEU GLN ASP ALA SEQRES 8 A 163 LYS LEU LEU VAL GLU GLY GLY VAL PRO ILE THR GLU ILE SEQRES 9 A 163 ASN ILE GLY ASN ILE HIS LYS THR ASP ASP LYS VAL ALA SEQRES 10 A 163 ILE THR GLN PHE ILE SER LEU GLY GLU THR ASP LYS SER SEQRES 11 A 163 ALA ILE ARG CYS LEU ALA HIS ASP HIS HIS VAL VAL PHE SEQRES 12 A 163 ASN THR LYS THR THR PRO ALA GLY ASN SER ALA SER ASP SEQRES 13 A 163 VAL ASP ILE LEU ASP TYR ILE SEQRES 1 B 163 GLY MSE THR GLN PRO ASN ILE ILE MSE THR ARG VAL ASP SEQRES 2 B 163 GLU ARG LEU ILE HIS GLY GLN GLY GLN LEU TRP VAL LYS SEQRES 3 B 163 PHE LEU ASN CYS ASN THR VAL ILE VAL ALA ASN ASP ALA SEQRES 4 B 163 VAL SER GLU ASP LYS ILE GLN GLN SER LEU MSE LYS THR SEQRES 5 B 163 VAL ILE PRO SER SER ILE ALA ILE ARG PHE PHE SER ILE SEQRES 6 B 163 GLN LYS VAL ILE ASP ILE ILE HIS LYS ALA SER PRO ALA SEQRES 7 B 163 GLN SER ILE PHE ILE VAL VAL LYS ASP LEU GLN ASP ALA SEQRES 8 B 163 LYS LEU LEU VAL GLU GLY GLY VAL PRO ILE THR GLU ILE SEQRES 9 B 163 ASN ILE GLY ASN ILE HIS LYS THR ASP ASP LYS VAL ALA SEQRES 10 B 163 ILE THR GLN PHE ILE SER LEU GLY GLU THR ASP LYS SER SEQRES 11 B 163 ALA ILE ARG CYS LEU ALA HIS ASP HIS HIS VAL VAL PHE SEQRES 12 B 163 ASN THR LYS THR THR PRO ALA GLY ASN SER ALA SER ASP SEQRES 13 B 163 VAL ASP ILE LEU ASP TYR ILE MODRES 3P3V MSE A 1 MET SELENOMETHIONINE MODRES 3P3V MSE A 8 MET SELENOMETHIONINE MODRES 3P3V MSE A 49 MET SELENOMETHIONINE MODRES 3P3V MSE B 1 MET SELENOMETHIONINE MODRES 3P3V MSE B 8 MET SELENOMETHIONINE MODRES 3P3V MSE B 49 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 8 8 HET MSE A 49 8 HET MSE B 1 8 HET MSE B 8 8 HET MSE B 49 8 HET PEG A 202 7 HET PGE B 200 10 HET PEG B 201 7 HET PEG B 203 7 HETNAM MSE SELENOMETHIONINE HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM PGE TRIETHYLENE GLYCOL FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 PEG 3(C4 H10 O3) FORMUL 4 PGE C6 H14 O4 FORMUL 7 HOH *293(H2 O) HELIX 1 1 ARG A 14 GLY A 18 5 5 HELIX 2 2 GLN A 19 LEU A 27 1 9 HELIX 3 3 ASN A 36 ASP A 42 1 7 HELIX 4 4 ASP A 42 LYS A 50 1 9 HELIX 5 5 THR A 51 ILE A 53 5 3 HELIX 6 6 SER A 63 ILE A 71 1 9 HELIX 7 7 HIS A 72 ALA A 74 5 3 HELIX 8 8 ASP A 86 GLY A 96 1 11 HELIX 9 9 GLY A 124 ASP A 137 1 14 HELIX 10 10 ASN A 151 ASP A 155 5 5 HELIX 11 11 ASP A 157 ILE A 162 5 6 HELIX 12 12 ARG B 14 GLY B 18 5 5 HELIX 13 13 GLN B 19 ASN B 28 1 10 HELIX 14 14 ASN B 36 GLU B 41 1 6 HELIX 15 15 ASP B 42 THR B 51 1 10 HELIX 16 16 SER B 63 ILE B 71 1 9 HELIX 17 17 HIS B 72 ALA B 74 5 3 HELIX 18 18 ASP B 86 GLY B 96 1 11 HELIX 19 19 GLY B 124 ASP B 137 1 14 HELIX 20 20 ASN B 151 ASP B 155 5 5 HELIX 21 21 ASP B 157 ILE B 162 5 6 SHEET 1 A 6 ALA A 58 PHE A 62 0 SHEET 2 A 6 THR A 31 ALA A 35 1 N VAL A 32 O ALA A 58 SHEET 3 A 6 SER A 79 VAL A 84 1 O PHE A 81 N ILE A 33 SHEET 4 A 6 ASN A 5 ASP A 12 1 N MSE A 8 O ILE A 82 SHEET 5 A 6 GLU A 102 ASN A 107 1 O ASN A 104 N THR A 9 SHEET 6 A 6 VAL A 141 ASN A 143 1 O ASN A 143 N ILE A 105 SHEET 1 B 2 VAL A 115 ALA A 116 0 SHEET 2 B 2 SER A 122 LEU A 123 -1 O LEU A 123 N VAL A 115 SHEET 1 C 6 ALA B 58 PHE B 62 0 SHEET 2 C 6 THR B 31 ALA B 35 1 N VAL B 32 O ALA B 58 SHEET 3 C 6 ILE B 80 VAL B 84 1 O PHE B 81 N ILE B 33 SHEET 4 C 6 ILE B 6 ASP B 12 1 N ASP B 12 O VAL B 84 SHEET 5 C 6 GLU B 102 ASN B 107 1 O ASN B 104 N THR B 9 SHEET 6 C 6 VAL B 141 ASN B 143 1 O VAL B 141 N ILE B 103 SHEET 1 D 2 VAL B 115 ALA B 116 0 SHEET 2 D 2 SER B 122 LEU B 123 -1 O LEU B 123 N VAL B 115 LINK C MSE A 1 N THR A 2 1555 1555 1.33 LINK C ILE A 7 N MSE A 8 1555 1555 1.33 LINK C MSE A 8 N THR A 9 1555 1555 1.33 LINK C LEU A 48 N MSE A 49 1555 1555 1.33 LINK C MSE A 49 N LYS A 50 1555 1555 1.32 LINK C GLY B 0 N MSE B 1 1555 1555 1.33 LINK C MSE B 1 N THR B 2 1555 1555 1.32 LINK C ILE B 7 N MSE B 8 1555 1555 1.32 LINK C MSE B 8 N THR B 9 1555 1555 1.34 LINK C LEU B 48 N MSE B 49 1555 1555 1.35 LINK C MSE B 49 N LYS B 50 1555 1555 1.33 CISPEP 1 GLN A 3 PRO A 4 0 -1.07 SITE 1 AC1 2 GLU A 13 LYS A 85 SITE 1 AC2 4 ARG B 60 GLN B 78 ASP B 112 VAL B 115 SITE 1 AC3 3 ILE A 117 GLU B 95 HOH B 327 SITE 1 AC4 4 ILE B 7 ASN B 143 LYS B 145 SER B 152 CRYST1 42.139 80.696 47.213 90.00 105.26 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023731 0.000000 0.006474 0.00000 SCALE2 0.000000 0.012392 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021955 0.00000 HETATM 1 N MSE A 1 30.113 -4.711 48.489 1.00 58.36 N ANISOU 1 N MSE A 1 9388 6987 5798 168 513 227 N HETATM 2 CA MSE A 1 30.141 -3.644 47.444 1.00 57.41 C ANISOU 2 CA MSE A 1 9076 6927 5808 150 464 165 C HETATM 3 C MSE A 1 31.139 -3.908 46.334 1.00 56.08 C ANISOU 3 C MSE A 1 8835 6753 5717 184 358 163 C HETATM 4 O MSE A 1 32.183 -4.534 46.561 1.00 57.88 O ANISOU 4 O MSE A 1 9145 6956 5888 258 278 191 O HETATM 5 CB MSE A 1 30.482 -2.298 48.068 1.00 57.04 C ANISOU 5 CB MSE A 1 8998 6941 5733 196 410 109 C HETATM 6 CG MSE A 1 29.300 -1.664 48.714 1.00 56.57 C ANISOU 6 CG MSE A 1 8939 6904 5649 153 525 88 C HETATM 7 SE MSE A 1 29.732 -0.202 49.935 0.75 43.11 SE ANISOU 7 SE MSE A 1 7279 5248 3851 221 474 22 SE HETATM 8 CE MSE A 1 30.062 -1.147 51.655 1.00 46.47 C ANISOU 8 CE MSE A 1 7956 5636 4064 276 489 78 C